Fund · State Street(R) SPDR(R) S & P 600(TM) Small Cap Growth ETF · measured from SEC filings
SLYG holdings
SLYG reports 348 holdings and behaves like 202.9 equally weighted ones, computed from its SEC Form N-PORT filing for 2026-06-30. The fact sheet publishes the first number; this page computes the second, and traces it across 28 quarters of filings.
Measured concentration
as of 2026-06-30Read this figure with the following in mind
2.5% of net assets is securities-lending cash collateral, excluded from the figure; counted as filed the fund would read 179.6
The figure below is what the filing says, published unchanged. What it may not do is sit beside a plain long-only fund and be read as the same quantity. How comparability is decided.
Computed by this site from the fund's SEC Form N-PORT filing; what the measure does not tell you · every fund in one table · hold it with other funds? X-ray the mix. Pricing: 100% at a quoted market price (level 1), 7 issuer countries, 0.13% restricted securities.
What stands out
as of 2026-06-30SLYG's largest investment is FormFactor Inc at 1.37% of net assets. Viasat Inc and Argan Inc follow; the three together are 3.93%. Ten companies are 10.91% of the fund; the other 338 share the rest. Among the 721 equity funds measured here, SLYG behaves like 202.9 holdings against a median of 42.4 — 4.8 times the median. Across 28 quarterly filings SLYG has held roughly steady since 2019-09-30 (218.9 then, 202.9 now). Between the 2026-03-31 and 2026-06-30 filings 23 positions were added and 16 dropped; 14.7% of the weight moved.
Each sentence is read from the fund's own SEC filing; the class median is computed across the comparable equity funds on this site. Nothing here is a view on the fund.
Every filing since 2019
28Between 2019-09-30 and 2026-06-30, SLYG went from behaving like 218.9 equally weighted positions to 202.9 — 7% fewer, while its top ten went from 9.56% to 10.91% of net assets. Read across the funds on the concentration-over-time table.
| Period | Holdings | Effective | Top 10 | Largest |
|---|---|---|---|---|
| 2026-06-30 | 348 | 202.9 | 10.91% | 1.37% |
| 2026-03-31 | 341 | 215.2 | 9.57% | 1.03% |
| 2025-12-31 | 335 | 209.4 | 10.45% | 1.21% |
| 2025-09-30 | 346 | 208.2 | 10.84% | 1.39% |
| 2025-06-30 | 342 | 206.6 | 10.45% | 1.17% |
| 2025-03-31 | 341 | 211.3 | 10.04% | 1.67% |
| 2024-12-31 | 339 | 213.7 | 9.85% | 1.2% |
| 2024-09-30 | 356 | 213.4 | 11% | 1.24% |
Earlier filings (20 more, back to 2019-09-30)
| Period | Holdings | Effective | Top 10 | Largest |
|---|---|---|---|---|
| 2024-06-30 | 348 | 205 | 11.43% | 1.5% |
| 2024-03-31 | 344 | 211.8 | 10.66% | 1.16% |
| 2023-12-31 | 343 | 211.6 | 10.83% | 1.37% |
| 2023-09-30 | 348 | 203.6 | 12.03% | 1.3% |
| 2023-06-30 | 349 | 204 | 11.7% | 1.41% |
| 2023-03-31 | 340 | 210.1 | 10.53% | 1.19% |
| 2022-12-31 | 340 | 213.6 | 10.14% | 1.15% |
| 2022-09-30 | 342 | 201.5 | 12.11% | 1.45% |
| 2022-06-30 | 336 | 202.4 | 11.49% | 1.25% |
| 2022-03-31 | 334 | 200.2 | 11.1% | 1.21% |
| 2021-12-31 | 332 | 201 | 10.8% | 1.45% |
| 2021-09-30 | 336 | 193.2 | 11.95% | 1.42% |
| 2021-06-30 | 335 | 204.5 | 10.62% | 1.34% |
| 2021-03-31 | 333 | 201.8 | 10.92% | 1.27% |
| 2020-12-31 | 335 | 194.3 | 11.3% | 1.35% |
| 2020-09-30 | 343 | 204.6 | 10.3% | 1.18% |
| 2020-06-30 | 339 | 206 | 10.08% | 1.19% |
| 2020-03-31 | 335 | 197 | 11.32% | 1.44% |
| 2019-12-31 | 333 | 220.1 | 9.34% | 1.54% |
| 2019-09-30 | 338 | 218.9 | 9.56% | 1.13% |
One row per filed reporting period, newest first, read from EDGAR. Quarterly because that is the public filing cadence. Rows marked * are published but held out of the comparison above; the methodology page says when and why.
As filed, collateral included
2.54% collateralSLYG's filing lists 349 positions including 2.54% of net assets in securities-lending cash collateral. Counted as filed the fund reads 179.6 effective holdings with a top ten of 12.54%; on its own investments — the figure above — it reads 202.9 with a top ten of 10.91%. The collateral is matched by a liability and is not a holding the fund chose; since 2026-09-18 every figure on this site sets it aside (methodology). Both numbers are in the data.
Largest positions, as filed
as of 2026-06-30The 15 largest of 348 positions in SLYG's Form N-PORT, weight as a share of net assets, securities-lending collateral excluded. Every position, every quarter: SLYG.csv.gz.
| # | Position | Weight | Cumulative |
|---|---|---|---|
| 1 | FormFactor Inc | 1.37% | 1.4% |
| 2 | Viasat Inc | 1.34% | 2.7% |
| 3 | Argan Inc | 1.22% | 3.9% |
| 4 | BrightSpring Health Services Inc | 1.21% | 5.1% |
| 5 | Krystal Biotech Inc | 1.07% | 6.2% |
| 6 | ESCO Technologies Inc | 0.99% | 7.2% |
| 7 | Alkermes PLC | 0.96% | 8.2% |
| 8 | Everus Construction Group Inc | 0.93% | 9.1% |
| 9 | StoneX Group Inc | 0.92% | 10.0% |
| 10 | Corcept Therapeutics Inc | 0.91% | 10.9% |
| 11 | Powell Industries Inc | 0.89% | 11.8% |
| 12 | Ryman Hospitality Properties Inc | 0.89% | 12.7% |
| 13 | Enpro Inc | 0.87% | 13.6% |
| 14 | Federal Signal Corp | 0.86% | 14.4% |
| 15 | MYR Group Inc | 0.85% | 15.3% |
By country of issuer
as of 2026-06-30Share of SLYG's own investments by the issuer country the filer reported (incorporation, not revenue). Each country links to every fund that holds it.
| Country | Share |
|---|---|
| United States | 96.68% |
| Ireland° | 0.96% |
| United Kingdom | 0.70% |
| Puerto Rico° | 0.55% |
| Bermuda° | 0.47% |
| Marshall Islands° | 0.34% |
| Bahamas | 0.31% |
Returns the fund reported
2019-07 – 2026-06Monthly total returns from Item B.5 of SLYG's own filings, 84 months on record. Not computed here and not from a price feed.
Cross-checked against a series computed separately from prices: median difference 0.07 percentage points over 84 months, which is roughly the distributions. Every month with the filing it came from: SLYG.json · all funds.
Who borrows SLYG's shares
2026-06-30The fund lends its holdings, and Item B.4.a of the filing names every firm holding them. At 2026-06-30, $761m was out to 24 borrowers, 14.65% of net assets. The largest, BARCLAYS BANK PLC, held 78.8% of it.
| Borrower | On loan | Share of the loan |
|---|---|---|
| BARCLAYS BANK PLC | $600m | 78.8% |
| BofA Securities, Inc. | $34m | 4.5% |
| National Financial Services LLC | $20m | 2.6% |
| UBS AG | $17m | 2.3% |
| GOLDMAN SACHS & CO. | $16m | 2.1% |
Cash collateral reported against the loan: 2.54% of net assets, 17.3% of the amount lent. That is a floor on the collateral, not the whole of it — collateral the fund does not hold as a position is not in this filing, so a figure under 100% is not evidence of under-collateralisation. How that figure behaves across all funds. Every quarter SLYG has filed, with each borrower: SLYG.json · all funds.
Since the previous filing
2026-03-31 → 2026-06-30340 positions became 347: 23 added (4.8% of the fund at the later date), 16 dropped (6.1% at the earlier date). Half the sum of all weight changes, a turnover proxy: 14.7%. Positions are matched on identifiers, so a security whose identifier changed shows as one drop and one add. Every filing of SLYG compared this way, as a feed: changes.xml · all funds: filings received.
| Largest increases | 2026-03-31 | 2026-06-30 | Largest decreases | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|---|
| ACM Research Inc | 0.28% | 0.79% | Primoris Services Corp | 1.03% | 0.59% |
| Viasat Inc | 0.83% | 1.34% | Installed Building Products Inc | 0.80% | 0.56% |
| BrightSpring Health Services Inc | 0.75% | 1.21% | Verra Mobility Corp | 0.30% | 0.07% |
| MaxLinear Inc | 0.08% | 0.51% | Shake Shack Inc | 0.47% | 0.24% |
| Corcept Therapeutics Inc | 0.50% | 0.91% | MarketAxess Holdings Inc | 0.44% | 0.24% |
| FormFactor Inc | 1.00% | 1.37% | TransMedics Group Inc | 0.45% | 0.25% |
New: Liquidia Corp (0.61%), Alignment Healthcare Inc (0.44%), Dave Inc (0.43%), Rush Street Interactive Inc (0.34%), Atmus Filtration Technologies Inc (0.32%), Remitly Global Inc (0.28%). Gone: Viavi Solutions Inc (1.02%), Sanmina Corp (0.94%), DigitalOcean Holdings Inc (0.90%), Semtech Corp (0.66%), Apellis Pharmaceuticals Inc (0.55%), Air Lease Corp (0.52%).
Asset categories and pricing
as of 2026-06-3097.46% equity, 2.54% short-term investment as filed; 100.0% carried at a quoted market price (fair-value level 1). Categories and levels are the filer's; what a low level-1 share does and does not mean is in the measure's page.
Neighbours by effective holdings, equity funds
10Every measured equity fund lined up by how many holdings it behaves like; these sit either side of SLYG (202.9). Same filings, same arithmetic. Position in this list says nothing about which fund is better.
| Fund | Reports | Behaves like | Top ten | As of |
|---|---|---|---|---|
| BTAL AGF U.S. Market Neutral Anti-Beta Fund | 202 | 198 * | 6.11% | 2026-06-30 |
| PXF Invesco RAFI Developed Markets ex-U.S. ETF | 1,019 | 198.1 | 14.58% | 2026-07-31 |
| EFA iShares MSCI EAFE ETF | 689 | 198.5 | 13.94% | 2026-07-31 |
| DON WisdomTree U.S. Midcap Dividend Fund | 294 | 201.2 | 10.69% | 2026-06-30 |
| SEIS SEI Select Small Cap ETF | 352 | 201.8 | 11.85% | 2026-06-30 |
| SCHF Schwab International Equity ETF | 1,478 | 203.6 | 14.87% | 2026-05-31 |
| DBEF Xtrackers MSCI EAFE Hedged Equity ETF | 723 | 206.1 | 13.55% | 2026-05-29 |
| INTF iShares International Equity Factor ETF | 498 | 208.5 | 12.83% | 2026-07-31 |
| IJJ iShares S&P Mid-Cap 400 Value ETF | 303 | 208.8 | 10.09% | 2026-06-30 |
| MDYV State Street(R) SPDR(R) S & P 400(TM) Mid Cap Value ETF | 302 | 209.2 | 10.07% | 2026-06-30 |
Essays that examine SLYG
0Mentions are detected across the full text of every article, so an appearance may be a passing comparison rather than the subject. Nothing here is a recommendation to buy or sell — see the disclaimer.